Observational Study to Evaluate Disease Course and Outcomes in Patients Treated With Esbriet (Pirfenidone) for Idiopathic Pulmonary Fibrosis (IPF) in Canada
Clinical trial NCT02552849 · COMPLETED
Trial details
- NCT number
- NCT02552849
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-04-25
- Primary completion
- 2017-08-15
- Enrollment
- 305
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.